Cumberland Pharmaceuticals Earnings: Here’s Why Investors are Buying Shares Now

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 4.17%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Cumberland Pharmaceuticals, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share increased 150% to $0.05 in the quarter versus EPS of $0.02 in the year-earlier quarter.

Revenue: Rose 0.39% to $10.3 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Cumberland Pharmaceuticals, Inc. reported adjusted EPS income of $0.05 per share. By that measure, the company met the mean analyst estimate of $0.05. It beat the average revenue estimate of $10 million.

Quoting Management: “Our progress during the first quarter included top line results from three new Caldolor studies and new international partnerships for India and Indonesia,” said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. “We were also pleased with the first quarter financial results maintaining revenues from the prior year quarter, while significantly increasing our net income through the efficient management of our expenses.”

Key Stats (on next page)…

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business